PulseAugur
EN
LIVE 09:48:25
ENTITY CAR-T cell therapy

CAR-T cell therapy

PulseAugur coverage of CAR-T cell therapy — every cluster mentioning CAR-T cell therapy across labs, papers, and developer communities, ranked by signal.

Show in brief
Total · 30d
1
4 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
1 over 90d
TIER MIX · 90D
TOPICS
TIMELINE
  1. 2026-09-16 research_milestone Experimental CAR T-cell therapy achieved complete regression of metastatic hepatoblastoma in a pediatric patient. source
SENTIMENT · 30D

1 day(s) with sentiment data

RECENT · PAGE 1/1 · 7 TOTAL
  1. COMMENTARY · CL_330977 ·

    General AI Surpasses Specialized Tools in Medicine, Alongside CAR-T Therapy Advances

    General-purpose AI models are demonstrating superior performance compared to specialized tools within the medical field. This advancement is occurring alongside promising long-term results for CAR-T cell therapy in trea…

  2. TOOL · CL_257557 ·

    Experimental CAR T-cell therapy eradicates aggressive pediatric liver cancer

    A three-year-old child with metastatic hepatoblastoma, a type of liver cancer resistant to chemotherapy, experienced a complete regression of their tumor. This remarkable outcome was achieved through two doses of an exp…

  3. TOOL · CL_220226 ·

    CAR-T Therapy Adapted to Treat Severe Allergies in Mice

    Researchers have adapted CAR-T cell therapy, typically used for cancer treatment, to potentially treat severe allergies. In a study involving mice, engineered immune cells were programmed to recognize a specific allerge…

  4. RESEARCH · CL_135055 ·

    Bay Island Cell secures 140M RMB for affordable CAR-T therapy development

    Bay Island Cell, a biotech firm founded by Fan Xiaohu, has secured 140 million RMB in Series A funding led by Songhe Capital. The company is developing a non-gene-edited universal CAR-T technology platform, aiming to pr…

  5. TOOL · CL_36810 ·

    CAR-T cell therapy shows early promise for HIV control

    Researchers are exploring CAR-T cell therapy, a technique successful in cancer treatment, as a potential method for long-term HIV control. A preliminary study suggests this approach may offer new avenues for managing th…

  6. SIGNIFICANT · CL_09633 ·

    Weitao Bio raises over $50M for in-vivo CAR-T therapy platform

    Weitai Bio, a company spun out from Shalier Bio, has secured over $50 million in Series A and A+ funding. The company is advancing its lead drug candidate, GT801, which utilizes a lipid nanoparticle (LNP) delivery syste…

  7. RESEARCH · CL_05459 ·

    AI accelerates cancer drug discovery, immunotherapy advances show promise

    Artificial intelligence is accelerating drug discovery for cancer treatments by rapidly identifying potential compounds. AI algorithms are also being integrated into clinical trial designs to improve efficiency and redu…